Zur Rose Group AG

  • ISIN: CH0042615283
  • Land: Schweiz

Nachricht vom 08.09.2020 | 07:00

Zur Rose and KPT together launch digital medicines assistant Medi+

EQS Group-News: Zur Rose Group AG / Key word(s): Alliance
08.09.2020 / 07:00

Bern and Frauenfeld, 8 September 2020

Press release

Zur Rose and KPT together launch digital medicines assistant Medi+

The new Medi+ service from Zur Rose supports patients in taking and managing their medicines. Medi+ makes it easier to deal with medicines, increases patient safety and helps avoid incorrect medication and the associated follow-up costs. KPT is the first health insurer to offer its patients a digital medicines assistant - free of charge.

Anyone who has to take medicines regularly knows that keeping track of them is a challenge. KPT customers now have a new free digital medicines assistant available round the clock, helping them to stay even more in control of their medicines and when they take them. Medi+ offers a range of handy functions that make dealing with medicines easier and safer.

Medi+ generates a personal medicines summary. With the user's consent, all medicines settled through KPT are displayed in the summary; others can easily be included on the list using a scan function. The summary also shows medicines already ordered from Zur Rose and prescriptions that have been submitted. So users of Medi+ always have an up-to-date summary of all the medicines they need to take - whether they are at home, or travelling. The application can also create a schedule of when medicines should be taken, with a reminder function. Follow-up online orders of prescription drugs at Zur Rose are easy, safe and economical with Medi+. But you don't have to buy your medicines from Zur Rose to use the application: people who are insured with KPT are at liberty to get their medicines from the doctor or from a pharmacy of their choice.

KPT CEO Reto Egloff sees great potential in the digital networking: "Medi+ makes it simpler for our customers to deal with their medicines every day - not least thanks to the simple data transfer from the KPTnet customer portal. KPT is making another major step forward in cooperative digital networking in healthcare."

Walter Hess, Head of Zur Rose Switzerland, adds: "With Medi+ we are offering customers and patients a service that is safe and that permanently improves the supply of medicines. Together with KPT we are providing a further contribution to making the healthcare system more efficient and therefore cheaper."



Pascale Ineichen, Head of Corporate Communications Zur Rose Suisse AG
Direct line +41 52 724 08 18 | Email media@zurrose.com

Beni Meier, Head of Corporate Communications KPT
Direct line +41 58 310 97 80 | Email: kommunikation@kpt.ch

Zur Rose Suisse AG

Zur Rose Suisse AG, a subsidiary of Zur Rose Group AG, is one of Switzerland's leading e-commerce pharmacies and medical wholesalers. With its business model, it offers high-quality, safe and cost-effective pharmaceutical care and thus contributes to reducing healthcare costs. It is also characterized by the continuous further development of digital services in the field of drug management using AI-supported applications and new technology. Zur Rose is furthermore actively driving ahead its positioning as a comprehensive provider of healthcare services. By creating a digital healthcare platform - the Zur Rose ecosystem - it networks products and digital services from qualified providers. The contribution made by Zur Rose will be to take these offerings to customers and patients and to make a relevant selection. The aim is to provide people with a seamless accompaniment and empower them to manage their own health optimally using products and digital solutions. For further information please see zurrose.ch and zurrosegroup.com.


KPT Group is based in Bern and is one of the ten largest health insurers in Switzerland. Over 600 employees offer a wealth of personal advice and innovative solutions to around 410,000 customers.

End of Corporate News

show this

Event im Fokus

Termine 2021

10. Juni 2021:Fachkonferenz Immobilien

14./15. Juli 2021: Fachkonferenzen Beteiligungsgesellschaften & Consumer/Leisure

13./14. Oktober 2021: Fachkonferenzen Finanzdienstleistungen/Technologie

10./11. November 2021: Fachkonferenzen Software/IT & Branchenmix

„Je nach aktueller Covid-19 Situation und den bestehenden Vorschriften für Versammlungen entscheidet sich ca. 5 Wochen vor dem Termin, in welcher Form die Konferenzen stattfinden.“


Cryptology Asset Group PLC: 120 % Kurspotenzial

GBC Research hat mit der Coverage der Cryptology Asset Group PLC (ISIN: MT0001770107) begonnen. Die Bewertung der führenden europäischen Investmentgesellschaft für Krypto-Assets und Blockchain-Unternehmen erfolgte mittels der Berechnung des Net Asset Value (NAV). Unter Berücksichtigung aller Beteiligungen ergibt sich zum 05. Juli 2021 eine GBC-Fair-NAV-Bewertung in Höhe von 1,04 Mrd. EUR. Daraus ergibt sich ein NAV je Cryptology-Aktie von 358,43 EUR. Daher empfiehlt GBC Research die Cryptology-Aktie zum Kauf und sieht ein Kurspotenzial von über 120 %.

News im Fokus

Delivery Hero startet globales Programm für nachhaltige Verpackungen zur Reduzierung von Plastikmüll

27. Juli 2021, 08:00

Aktueller Webcast


H1 2021 Analyst Call

04. August 2021

Aktuelle Research-Studie

Schweizer Electronic AG

Original-Research: Schweizer Electronic AG (von Montega AG): Halten

27. Juli 2021